Palmetto Clinical Trial Services, LLC   Report issue

For profit Phase 3 Phase 4
Founded: Greenville SC United States (2002)

Organization Overview

First Clinical Trial
2010
NCT01138735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Palmetto Clinical Trials Services, LLC

Active Ingredients

Drugs in Phase 4 Trials (2)

adapalene (differin) (1 trial)

benzoyl peroxide (clearasil) (1 trial)

Drugs in Phase 3 Trials (2)

brimonidine (alphagan) (2 trials)

meloxicam (mobic) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Erythema (Phase 3)

Osteoarthritis (Phase 3)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 4